|
RP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.452630E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.891800E-01 |
| Normal-vs-Stage2 |
1.381200E-01 |
| Normal-vs-Stage3 |
9.054400E-02 |
| Normal-vs-Stage4 |
8.881000E-03 |
| Stage1-vs-Stage2 |
3.121800E-01 |
| Stage1-vs-Stage3 |
1.502410E-01 |
| Stage1-vs-Stage4 |
2.175600E-02 |
| Stage2-vs-Stage3 |
9.444800E-01 |
| Stage2-vs-Stage4 |
3.398400E-01 |
| Stage3-vs-Stage4 |
3.322600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.729570E-01 |
| Normal-vs-AfricanAmerican |
5.417000E-01 |
| Normal-vs-Asian |
1.512830E-01 |
| Caucasian-vs-AfricanAmerican |
7.345400E-01 |
| Caucasian-vs-Asian |
6.658400E-01 |
| AfricanAmerican-vs-Asian |
5.599200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.171800E-02 |
| Normal-vs-Female |
2.355000E-01 |
| Male-vs-Female |
2.163600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.441600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.272300E-02 |
| Normal-vs-Age(61-80Yrs) |
3.368000E-02 |
| Normal-vs-Age(81-100Yrs) |
7.785200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.195100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.197740E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.566400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.024200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.576800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.585000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.283000E-01 |
| Classical-VS-Follicular |
2.001600E-01 |
| Classical-VS-Other |
2.476200E-01 |
| Classical-VS-Normal |
3.900600E-01 |
| Tall-VS-Follicular |
9.848600E-01 |
| Tall-VS-Other |
5.602200E-01 |
| Tall-VS-Normal |
2.375400E-01 |
| Follicular-VS-Other |
4.947200E-01 |
| Follicular-VS-Normal |
1.075040E-01 |
| Other-VS-Normal |
1.245200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.825600E-02 |
| Normal-vs-N1 |
5.853700E-02 |
| N0-vs-N1 |
9.640600E-01 |
|
|
